NUTEX HEALTH INC (NUTX)

US67079U2078 - Common Stock

0.6616  +0.01 (+1.33%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
18.8M
1,075.00%		219.3M
1,066.49%		247.646M
12.93%		322.52M
30.23%		N/A
EBITDA
YoY % growth
-8.29M
-143.82%		8.53M
202.90%		16.3M
91.09%		21.114M
29.53%
EBIT
YoY % growth
-9M
-157.14%		-4.6M
48.89%		-1.292M
71.92%		9.18M
810.80%
Operating Margin
-47.87%-2.10%-0.52%2.85%N/A
EPS
YoY % growth
N/AN/A-0.31-0.01
96.71%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		0.00
Revenue
Q2Q % growth		66.096M
17.34%
EBITDA
Q2Q % growth		4.08M
EBIT
Q2Q % growth		714K
116.88%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.00
100.00%		0.000.00%
Q3 2023
Q2Q % growth		 -0.15 -0.08-0.07-96.08%
Q2 2023
Q2Q % growth		 -0.15
-400.00%		-0.08-0.07-96.08%
Q1 2023
Q2Q % growth		 -0.01 -0.020.0134.64%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 69.669M
29.69%		72.828M-3.159M-4.34%
Q3 2023
Q2Q % growth		 62.72M
120.85%		64.515M-1.795M-2.78%
Q2 2023
Q2Q % growth		 58.92M
1.50%		63.291M-4.371M-6.91%
Q1 2023
Q2Q % growth		 56.33M
-28.81%		57.171M-841K-1.47%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 33.33%
Revenue-7.82% -10.74% 0% 8.47%